
Auteur M. HELLARD
|
Documents disponibles écrits par cet auteur (6)

R. SACKS-DAVIS ; D. HORYNIAK ; J. GREBELY ; M. HELLARD | 2012
Dans International Journal of Drug Policy (Vol.23, n°3, May 2012) Article : PériodiqueBACKGROUND: A systematic review was conducted to determine whether behavioural interventions are effective in preventing transmission of hepatitis C virus (HCV) amongst people who inject drugs. METHODS: Medline, EMBASE, the Cochrane Clinical T[...]
K. DOLAN ; A. L. WIRTZ ; B. MOAZEN ; M. NDEFFO-MBAH ; A. GALVANI ; S. A. KINNER ; R. COURTNEY ; M. McKEE ; J. J. AMON ; L. MAHER ; M. HELLARD ; C. BEYRER ; F. L. ALTICE | 2016
Dans Lancet (The) (Vol.388, n°10049, September 10, 2016) Article : PériodiqueThe prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We did a comprehensive literature search of data published between 2005 and 2015 to understand t[...]
C. K. AITKEN ; J. LEWIS ; S. L. TRACY ; T. SPELMAN ; D. S. BOWDEN ; M. BHARADWAJ ; H. DRUMMER ; M. HELLARD | 2008
PériodiqueAn estimated 170 million people worldwide carry the hepatitis C virus (HCV), and in more developed countries the prevalence and incidence of HCV is particularly high among injecting drug users (IDUs). Spontaneous clearance of HCV infection and r[...]
J. GREBELY ; G. ROBAEYS ; P. BRUGGMANN ; A. AGHEMO ; M. BACKMUND ; J. BRUNEAU ; J. BYRNE ; O. DALGARD ; J. J. FELD ; M. HELLARD ; M. HICKMAN ; A. KAUTZ ; A. LITWIN ; A. R. LLOYD ; S. MAUSS ; M. PRINS ; T. SWAN ; M. SCHAEFER ; L. E. TAYLOR ; G. J. DORE | 2023
Dans International Journal of Drug Policy (Vol.111, January 2023) Article : PériodiqueDans les pays à revenus élevés, la majorité des infections par le virus de l'hépatite C (VHC) nouvelles et existantes se produisent chez usagers de drogues par injection (UDI). Dans de nombreux pays à revenus faibles et moyens, de vastes épidémi[...]Nouveauté
J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : PériodiqueGlobally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]
E. ASPINALL ; S. J. HUTCHINSON ; A. TAYLOR ; N. E. PALMATEER ; M. HELLARD ; E. ALLEN ; D. GOLDBERG | 2012
Dans Drug and Alcohol Dependence (Vol.126, n°3, December 2012) Article : PériodiqueBackground: There has been a significant increase in the provision of injecting paraphernalia from Scottish injecting equipment provision (IEP) services. However, there is currently a lack of evidence on whether uptake of paraphernalia has any i[...]